UCB Pharma GMBH
USPTO PatentsView assignee record - 23 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, UCB ranks #13,222 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 11 technology areas.
- #13,222
- of 49,997 US assignees by volume
- Top 6%
- by Innovation Score (56.2/100)
- 22.4
- avg claims per patent
- -71%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13222 · Foreign Corporation #13,222 · 23 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 23 grants
- MID-PACK #13,222/49,997
- PHOTO-FINISH Tuskegee University
- CPC-FOCUS A61P · 11 areas
- INNOV-PAR 56.2/100
- CLAIMS-DENSE 22.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -71% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Tuskegee University (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How UCB’s 56.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around UCB
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- UCB Pharma · this assignee
UCB Pharma · this assignee
56 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows UCB's Innovation Score is 56.2/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for UCB?
Each dot is one of UCB’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). UCB’s own 22.4 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where UCB's grants concentrate
UCB Pharma GMBH is a focused PatentsView assignee: 11 CPC subclasses with 82.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (8 grants) versus a trough of 1 in 2017. By volume, UCB sits between Tuskegee University and University OF Calcutta.
UCB's three-year grant acceleration
UCB Pharma GMBH shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at UCB's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Tuskegee Universi…
Tuskegee University
23 patents
- Tyco Brasil Ltda
Tyco Electronics Brasil Ltda
23 patents
- Tyco Svenska AB
Tyco Electronics Svenska AB
23 patents
- U S Bancorp Natio…
U.S. Bancorp, National Association
23 patents
- United Airlines
United Airlines, Inc.
23 patents
- Universitetet I O…
Universitetet I Oslo
23 patents
- University FOR At…
University Corporation FOR Atmospheric Research
23 patents
- University OF Cal…
University OF Calcutta
23 patents
- UCB Pharma ◀
UCB Pharma GMBH
23 patents
What this shows UCB holds 23 patents at rank #13,217, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near UCB
By rank, the assignees closest to #13,217 in granted patent volume.
- Tuskegee University #13,213 · 23 patents
- Tyco Electronics Brasil Ltda #13,214 · 23 patents
- Tyco Electronics Svenska AB #13,215 · 23 patents
- U.S. Bancorp, National Association #13,216 · 23 patents
- United Airlines, Inc. #13,218 · 23 patents
- Universitetet I Oslo #13,219 · 23 patents
- University Corporation FOR Atmospheric Research #13,220 · 23 patents
- University OF Calcutta #13,221 · 23 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in UCB's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
UCB's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
56 Top 6% higher than 94% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 8 | 34.8% |
| 2016 | 4 | 17.4% |
| 2017 | 1 | 4.3% |
| 2018 | 3 | 13.0% |
| 2019 | 1 | 4.3% |
| 2022 | 1 | 4.3% |
| 2023 | 1 | 4.3% |
| 2024 | 3 | 13.0% |
| 2025partial year | 1 | 4.3% |
Which technologies does UCB Pharma GMBH patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
UCB Pharma GMBH's patent record in context - here's where to go next.
- UCB Pharma GMBH's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 82.6% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #13,222 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare UCB Pharma GMBH against Tuskegee University, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 56.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.